Investment Bank for the Healthcare Sector
With insights and relationships throughout the healthcare ecosystem, our team excels at securing ideal partners to create value for our clients.
45+
healthcare transactions in 2023
>65%
healthcare sell-side M&A transactions with private equity clients in 2023
Providing Quality Outcomes for Healthcare Clients
Healthcare is one of the most dynamic and complex areas in the global economy. Healthcare leaders who want to capitalize on rapid changes in science, regulation, technology and therapeutics benefit from the expertise of investment banking advisors with relevant experience and a keen focus on their unique goals. Our passion for healthcare and our focus on creating shareholder value for our clients has made us one of the fastest growing investment banking advisors for healthcare sector.
Sector Focus
Provider Services
Home Healthcare
Physician Services
Outpatient Services
Pharmacy Services
Pharmaceutical & Lab Services
Contract Research Organizations
Analytical Lab Services
Clinical Lab Services
Contract Manufacturing
Medical Communications
Process Outsourcing
Hospital Outsourcing
Revenue Cycle Management
Employer Health Services
Healthcare IT
Medical Devices & Outsourcing
Devices & Equipment
Products & Supplies
Medical Components
Contract Design / Manufacturing
Life Sciences
Diagnostic Instruments
Research Equipment
Lab Supplies
Consumables & Kits
Managed Care
Health Plans
Third-Party Administration
Benefits Management
Payor Outsourced Services
Perspectives & Publications
PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market
Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More
“Leader to Leader” Series
The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More
What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access
The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More
Lincoln’s expertise in healthcare services and with private companies, combined with their process execution capabilities, proved to be invaluable. At all times the Lincoln team acted as a trusted advisor and truly understood the needs of an owner-entrepreneur."
Recent Transactions in Healthcare
American & European Healthcare Group Heads
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | European Co-head Healthcare
FrankfurtMeet our Senior Team with Healthcare Expertise
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | European Co-head Healthcare
Frankfurt
